Avanafil Enhances Sexual Performance and Satisfaction in American Men with CKD: A Longitudinal Study
Reading Time: 2 minutesIntroduction Chronic Kidney Disease (CKD) affects millions of American men, often leading to a decline in sexual function and satisfaction. This longitudinal study investigates the impact of Stendra (Avanafil), a phosphodiesterase type 5 (PDE5) inhibitor, on sexual performance and satisfaction in this population. By examining the efficacy and safety of Avanafil, we aim to provide valuable insights for healthcare providers... Read more »
